The subsidies allow insurers to hold down overall premiums under the Affordable Care Act.
A federal judge has found that the Trump administration can stop making cost-sharing reductions (CSRs) while weighing a state program to keep the insurer subsidies intact.
Judge Vince Chhabria denied a preliminary injunction to 18 states and the District of Columbia, which sought to keep the subsidies under the Affordable Care Act (ACA) intact. The CSRs help insurers hold down overall premiums while meeting the ACA requirements to keep down costs for Americans with the lowest income.
While acknowledging the CSRs had helped achieve a core goal of the ACA—dramatically lowering rates of the uninsured—Chhabria wrote that the states failed to meet the bar needed for a preliminary injunction, and suggests that the administration likely has the stronger argument. House Republicans had sued, and won a lower court ruling that Congress had not, in fact, appropriated funds for the CSRs.
Chhabria wrote, in fact, that “the emergency relief sought by the states would be counterproductive.”
Bipartisan legislation being considered in the Senate, sponsored by Senators Lamar Alexander, R-Tennessee, and Patty Murray, D-Washington, would restore the CSRs through 2019 and grant states additionally flexibility to craft waivers. Yesterday, the Congressional Budget Office found that the legislation would reduce the deficit by $3.8 billion while keeping coverage rates stable.
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Polatuzumab Vedotin and R-CHP Appropriate for Untreated DLBCL
April 24th 2024Population pharmacokinetic and exposure-response analyses revealed a favorable benefit-risk profilane for the treatment combination of polatuzumab vedotin and rituximab, cyclophosphamide, doxorubicin, and prednisone (R-CHP).
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More